ATE Stock Price, Chart, Stats & News

Antibe Therapeutics Inc.
Save
Antibe Therapeutics Inc. (ATE) does not currently pay a dividend.
15.64M
Market cap
–
Current P/E
–
Forward P/E
ATE chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Devices
Industry
Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs.
Similar securities
Based on sector and market capitalization
Report issue











